Skip NavigationSkip to Content

Non-Hodgkin's B cell lymphoma in persons with acquired immunodeficiency syndrome is associated with increased serum levels of IL10, or the TL10 promoter-592 C/C genotype

  1. Author:
    Breen, E. C.
    Boscardin, W. J.
    Detels, R.
    Jacobson, L. P.
    Smith, M. W.
    O'Brien, S. J.
    Chmiel, J. S.
    Rinaldo, C. R.
    Lai, S. H.
    Martinez-Maza, O.
  2. Author Address

    Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, CHS 27-139, Los Angeles, CA 90095 USA Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90095 USA Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA Sci Applicat Int Corp, Intramural Res Support Program, Ft Detrick, MD 21702 USA Natl Canc Inst Frederick, Lab Genom Divers, Ft Detrick, MD 21702 USA Northwestern Univ, Sch Med, Dept Prevent Med, Chicago, IL 60611 USA Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA Breen EC Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, CHS 27-139, Los Angeles, CA 90095 USA
    1. Year: 2003
  1. Journal: Clinical Immunology
    1. 109
    2. 2
    3. Pages: 119-129
  2. Type of Article: Article
  1. Abstract:

    Interleukin-10 (IL10) may contribute to the development of non- Hodgkin's B cell lymphoma, especially in the context of acquired immunodeficiency syndrome (AIDS), where lymphoma incidence is greatly increased. Utilizing specimens from the Multicenter AIDS Cohort Study (MACS) obtained prior to diagnosis of AIDS-associated lymphoma, detectable serum human IL10 was seen much more frequently in lymphoma cases (n = 61, 26%) compared to CD4-matched AIDS controls (5%, P = 0.004), or to HIV-infected (2%, P = 0.002) or HIV uninfected subjects (0%, P = 0.0003). In longitudinal studies, detectable IL10 occurred at times closest to but preceding lymphoma diagnosis (P = 0.01). In an independent genetic analysis of single-nucleotide polymorphisms within the promoter region of the IL10 gene in 1157 MACS subjects, a high IL10-expressing genotype (-592 C/C) was overrepresented among lymphoma subjects (P = 0.009), even when controlling for race (P = 0.006). These results suggest that elevated serum IL10 or the IL10 promoter -592 C/C genotype are associated with development of AIDS lymphoma. (C) 2003 Elsevier Inc. All rights reserved.

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel